Singapore markets close in 2 hours 26 minutes
Straits Times Index
3,401.85 -8.96 (-0.26%) Nikkei
40,780.70 -131.67 (-0.32%) Hang Seng
17,481.93 -317.68 (-1.78%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
55,759.58 -1,963.66 (-3.40%) CMC Crypto 200
1,149.85 -16.27 (-1.40%)
AstraZeneca PLC (ZEG.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 143.75 |
| Open | 144.00 |
| Bid | 0.00 x 30000 |
| Ask | 0.00 x 30000 |
| Day's range | 142.00 - 144.05 |
| 52-week range | 112.35 - 150.60 |
| Volume | |
| Avg. volume | 29,281 |
| Market cap | 220.991B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 38.01 |
| EPS (TTM) | 3.75 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 2.65 (1.86%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
ZacksAstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
The European Commission approves AstraZeneca's (AZN) Tagrisso in combination with chemotherapy for first-line treatment of advanced EGFR-mutated NSCLC based on data from the phase III FLAURA2 study.
ZacksPharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in Europe.
Simply Wall St.Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
© 2024 Yahoo. All rights reserved.